# Pulmonx Corp: Form 8-K, filed Mar 5, 2026

- Company: [Pulmonx Corp](/companies/lung.md) (CIK 1127537)
- Form: 8-K
- Filed: 2026-03-05
- Accepted by EDGAR: Mar 4, 2026, 19:10 ET
- Period: 2026-03-02
- Accession: 0001193125-26-092064
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1127537/000119312526092064/d126478d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1127537/000119312526092064/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 1.02: Termination of a material agreement
- Item 2.03: New direct financial obligation
- Item 3.02: Unregistered sale of equity
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1127537/000119312526092064/d126478d8k.htm

Filed Mar 5, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-092064. Last ingested by Listed: Nov 5, 2026, 15:33 ET. No prices; not investment advice.
